Under construction – not a live service
Sign in

2026-526026-40-00RecruitingPhase 2/3

Study of an Injectable Regimen of GS-3242 with Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

An Operationally Seamless Phase 2/3 Randomized, Open-label, Active-Controlled Study Evaluating the Safety and Efficacy of an Injectable Regimen of GS-3242 in Combination with Lenacapavir Versus Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Treatment-Naive People With HIV-1

Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Oct 2026

Next steps

Brief summary (registry, in English)

1. Phase 2: Part A: To evaluate the efficacy of GS-3242 plus lenacapavir (LEN, Sunlenca®) versus bictegravir/emtricitabine/tenofovir alafenamide (coformulated; Biktarvy®) (B/F/TAF; 50/200/25 mg) in treatment-naive people with HIV-1 (PWH) in Treatment Groups 1, 2, and 3 at Week 35 2. Phase 2: Part B: To evaluate the efficacy of GS-3242 plus LEN versus B/F/TAF in treatment-naive PWH in Treatment Groups 4 and 3 at Week 26 3. Phase 3: To evaluate the efficacy of GS-3242 plus LEN versus B/F/TAF in treatment-naive PWH at Week 52

Status (registry)
Recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
185 (estimated)
First submitted
29 Jun 2026
Start date
28 Oct 2026
Lead sponsor
Gilead Sciences Inc.
Diseases
HIV
EU CT number
2026-526026-40-00

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 185
  • 27 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior usage of, or exposure to LEN or GS-3242
  • Prior use of any long-acting parenteral ARV therapy (ART) medications such as monoclonal antibodies or broadly neutralizing antibodies targeting HIV-1, injectable cabotegravir (including oral cabotegravir lead-in), or injectable rilpivirine

Who the study is looking for

  • HIV-1 RNA ≥ 500 copies/mL at screening
  • ARV treatment-naive, except for prior use of oral daily PrEP or PEP up to 1 month prior to screening

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (27)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universitaetsklinikum Bonn AöRBonnGermanyRecruiting
Universitaetsklinikum Essen (AoR)EssenGermanyRecruiting
Infektio Research GmbH & Co. KGFrankfurt Am MainGermanyRecruiting
ICH Study Center Gmbh & Co. KGHamburgGermanyRecruiting
Medizinische Hochschule HannoverHanoverGermanyRecruiting
Hospital Clinic de BarcelonaBarcelonaSpainRecruiting
Hospital Universitario Virgen de las NievesGranadaSpainRecruiting
Bellvitge University HospitalL'hospitalet De LlobregatSpainRecruiting
Hospital Universitario Infanta LeonorMadridSpainRecruiting
Hospital Universitario La PazMadridSpainRecruiting
Hospital Clinico Universitario de ValenciaValenciaSpainRecruiting
Wojewodzki Szpital Obserwacyjno-Zakazny Im Tadeusza BrowiczaBydgoszczPolandNot yet recruiting
Punkt Zdrowia Hlebowicz Jakubowski Lekarze sp. p.GdanskPolandNot yet recruiting
Samodzielny Publiczny Wojewódzki Szpital Zespolony w SzczecinieSzczecinPolandNot yet recruiting
Wroclawskie Centrum Zdrowia Samodzielny Publiczny Zaklad Opieki ZdrowotnejWroclawPolandNot yet recruiting
Unidade Local De Saude De Almada-Seixal E.P.E.AlmadaPortugalNot yet recruiting
Unidade Local De Saude De Amadora Sintra E.P.E.AmadoraPortugalNot yet recruiting
Unidade Local De Saude De Lisboa Ocidental E.P.E.LisbonPortugalNot yet recruiting
Unidade Local De Saude De Santa Maria E.P.E.LisbonPortugalNot yet recruiting
Unidade Local De Saude De Santo Antonio E.P.E.PortoPortugalNot yet recruiting
Unidade Local de Saude de Sao Joao E.P.E.PortoPortugalNot yet recruiting
Spitalul Clinic De Urgenta Prof Dr Agrippa IonescuBaloteştiRomaniaNot yet recruiting
Institutul National de Boli Infectioase "Prof.Dr. Matei Bals"BucharestRomaniaNot yet recruiting
Spitalul Clinic De Boli Infectioase Cluj-NapocaCluj-NapocaRomaniaNot yet recruiting
Spitalul Clinic De Boli Infectioase ConstantaConstantaRomaniaNot yet recruiting
Spitalul Clinic De Boli Infectioase Sf. Parascheva IasiJassiRomaniaNot yet recruiting
Clinical Hospital of Infectious Diseases and Pneumophysiology Dr.Victor Babeș TimișoaraTimișoaraRomaniaNot yet recruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.